小肠结肠炎耶尔森菌：七种新型β-内酰胺抗生素的体外活性比较
Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics.
作者信息
Scribner R K, Marks M I, Weber A, Pai C H
出版信息
Antimicrob Agents Chemother. 1982 Jul;22(1):140-1. doi: 10.1128/AAC.22.1.140.
Abstract
Minimum inhibitory concentrations of seven new beta-lactam derivatives were determined against 35 isolates of Yersinia enterocolitica. Ceftizoxime and ceftriaxone were the most active of the antimicrobial agents tested.
摘要
测定了七种新型β-内酰胺衍生物对35株小肠结肠炎耶尔森菌的最低抑菌浓度。头孢唑肟和头孢曲松是所测试抗菌剂中活性最强的。
相似文献
1
Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics.小肠结肠炎耶尔森菌：七种新型β-内酰胺抗生素的体外活性比较
Antimicrob Agents Chemother. 1982 Jul;22(1):140-1. doi: 10.1128/AAC.22.1.140.
2
Susceptibility of Yersinia enterocolitica to eight beta-lactam antibiotics and clavulanic acid.小肠结肠炎耶尔森菌对八种β-内酰胺类抗生素及克拉维酸的敏感性。
J Antimicrob Chemother. 1981 Aug;8(2):161-4. doi: 10.1093/jac/8.2.161.
3
In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.126株小肠结肠炎耶尔森菌临床分离株对21种β-内酰胺类抗生素的体外敏感性
Antimicrob Agents Chemother. 1985 May;27(5):806-11. doi: 10.1128/AAC.27.5.806.
4
5
6
Comparative activities of 13 beta-lactam antibiotics.13种β-内酰胺类抗生素的比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):925-34. doi: 10.1128/AAC.21.6.925.
7
Antibiotic susceptibilities of Yersinia enterocolitica and Y. intermedia isolates from aquatic environments.来自水生环境的小肠结肠炎耶尔森氏菌和中间型耶尔森氏菌分离株的抗生素敏感性
J Med Microbiol. 1999 Feb;48(2):157-160. doi: 10.1099/00222615-48-2-157.
8
In-vitro and in-vivo activities of beta-lactam antibiotics on Yersinia enterocolitica.β-内酰胺类抗生素对小肠结肠炎耶尔森菌的体外和体内活性
J Antimicrob Chemother. 1992 Apr;29(4):456-9. doi: 10.1093/jac/29.4.456.
9
Yersinia enterocolitica infection in a compromised host.免疫功能低下宿主的小肠结肠炎耶尔森菌感染
Singapore Med J. 1979 Dec;20(4):457-9.
10
Susceptibility profiles of Yersinia spp strains to beta-lactams and other major classes of antimicrobials.耶尔森菌属菌株对β-内酰胺类及其他主要抗菌药物的敏感性谱
J Chemother. 1989 Jul;1(4 Suppl):319-22.
引用本文的文献
1
Yersinia enterocolitica: the charisma continues.小肠结肠炎耶尔森菌：魅力依旧。
Clin Microbiol Rev. 1997 Apr;10(2):257-76. doi: 10.1128/CMR.10.2.257.
2
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢噻肟：抗菌活性、药理特性及治疗用途综述
Drugs. 1983 Mar;25(3):223-89. doi: 10.2165/00003495-198325030-00001.
3
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
4
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
5
Antimicrobial susceptibilities of food-isolated strains of Yersinia enterocolitica, Y. intermedia, Y. frederiksenii, and Y. kristensenii.食品分离的小肠结肠炎耶尔森菌、中间型耶尔森菌、费氏耶尔森菌和克氏耶尔森菌菌株的抗菌药敏性。
Antimicrob Agents Chemother. 1985 Aug;28(2):351-3. doi: 10.1128/AAC.28.2.351.
6
Faecal carriage rate of Yersinia species.耶尔森菌属的粪便携带率。
J Hyg (Lond). 1986 Oct;97(2):281-7. doi: 10.1017/s0022172400065372.
7
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.氨曲南。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.
8
Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.新型β-内酰胺类抗生素对小鼠小肠结肠炎耶尔森菌感染治疗失败。
Antimicrob Agents Chemother. 1987 Apr;31(4):523-6. doi: 10.1128/AAC.31.4.523.
9
Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢甲肟。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1987 Aug;34(2):188-221. doi: 10.2165/00003495-198734020-00002.
10
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估，以及关于其治疗用途的最新情况，特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.
本文引用的文献
1
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.八种β-内酰胺酶稳定型头孢菌素对产β-内酰胺酶革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13. doi: 10.1128/AAC.19.3.407.
2
Yersinia enterocolitica infections in children.儿童耶尔森氏小肠结肠炎杆菌感染
J Pediatr. 1976 Jul;89(1):77-9. doi: 10.1016/s0022-3476(76)80932-8.
3
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3.小肠结肠炎耶尔森菌生物4型、血清型O:3的抗菌药敏性
Antimicrob Agents Chemother. 1977 Mar;11(3):566-8. doi: 10.1128/AAC.11.3.566.
4
Yersinia enterocolitica: in vitro antimicrobial susceptibility.小肠结肠炎耶尔森菌：体外抗菌药敏性
Antimicrob Agents Chemother. 1978 May;13(5):888-90. doi: 10.1128/AAC.13.5.888.
5
Summary of the data received at the WHO Reference Center for Yersinia enterocolitica.世界卫生组织小肠结肠炎耶尔森菌参考中心收到的数据摘要。
Contrib Microbiol Immunol. 1979;5:174-84.
6
Yersinia enterocolitica epidemiology and antibiotic susceptibility.小肠结肠炎耶尔森菌的流行病学及抗生素敏感性
J Antimicrob Chemother. 1979 May;5(3):241-4. doi: 10.1093/jac/5.3.241.
Zotero 插件